Success Metrics

Clinical Success Rate
94.4%

Based on 17 completed trials

Completion Rate
94%(17/18)
Active Trials
0(0%)
Results Posted
12%(2 trials)
Terminated
1(5%)

Phase Distribution

Ph not_applicable
2
9%
Ph phase_1
18
82%
Ph phase_3
1
5%
Ph early_phase_1
1
5%

Phase Distribution

19

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution22 total trials
Early Phase 1First-in-human
1(4.5%)
Phase 1Safety & dosage
18(81.8%)
Phase 3Large-scale testing
1(4.5%)
N/ANon-phased studies
2(9.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

89.5%

17 of 19 finished

Non-Completion Rate

10.5%

2 ended early

Currently Active

0

trials recruiting

Total Trials

22

all time

Status Distribution
Active(2)
Completed(17)
Terminated(2)
Other(1)

Detailed Status

Completed17
Not yet recruiting2
Terminated1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
0
Success Rate
94.4%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (4.5%)
Phase 118 (81.8%)
Phase 31 (4.5%)
N/A2 (9.1%)

Trials by Status

terminated15%
completed1777%
withdrawn15%
unknown15%
not_yet_recruiting29%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT04255277Phase 1

To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.

Completed
NCT01689116Phase 1

Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers

Completed
NCT05830071Phase 1

A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV)

Completed
NCT06310876Phase 1

A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects

Completed
NCT06210269Not Applicable

Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute Appendicitis

Not Yet Recruiting
NCT05917340Phase 3

Intensified Short Course Regimen for TBM in Adults

Not Yet Recruiting
NCT04692623Phase 1

EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY

Completed
NCT04873570Phase 1

Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects

Completed
NCT03657264Phase 1

Cardiac Safety Evaluation of P03277

Completed
NCT04966325Early Phase 1

Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects

Completed
NCT00485667Phase 1

Phase 1 Thorough QT Study in Young Healthy Volunteers

Completed
NCT03516630Phase 1

Effects of Three Single Oral Doses of Trazodone on the QTc Interval Duration in Healthy Volunteers

Completed
NCT04045769Phase 1

A Study to Evaluate the Effect of Saroglitazar Magnesium on the QTc Interval in Healthy Volunteers

Completed
NCT03021616Not Applicable

Evaluation of Energy Drinks on Electrocardiographic, Vascular and Hematologic Parameters in Healthy Volunteers

Terminated
NCT04238195Phase 1

A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects

Completed
NCT04168723Phase 1

TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects

Unknown
NCT03577275Phase 1

A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval

Completed
NCT03709927Phase 1

4-way Crossover QT Evaluation in Healthy Subjects

Completed
NCT03554304Phase 1

Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers

Completed
NCT01209026Phase 1

Corrected QT (QTc) Study With Flucticasone Furoate and GW642444

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22